Urologic and interventional radiology treatment of renal cell carcinomas—similarities and differences

Diep Nguyen, Eric vanSonnenberg, Paul Kang, Peter R. Mueller


Treatment modalities for renal cell carcinoma (RCC) have evolved and broadened as alternatives to traditional nephrectomy. Based on incidence rates in the U.S., the American Cancer Society projects 73,820 new cases of renal cancer in 2019, with 94% of them being RCCs (1). In 2015, the prevalence of RCC in the U.S. was reported to be 505,380 (2).